日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer

抑制ULK1/2和KRASG12C可控制肺癌临床前模型中的肿瘤生长

Phaedra C Ghazi ,Kayla T O'Toole ,Sanjana Srinivas Boggaram ,Michael T Scherzer ,Mark R Silvis ,Yun Zhang ,Madhumita Bogdan ,Bryan D Smith ,Guillermina Lozano ,Daniel L Flynn ,Eric L Snyder ,Conan G Kinsey ,Martin McMahon

Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy

VPS34抑制剂与STING激动剂联用可增强I型干扰素信号传导和抗肿瘤疗效

Yasmin Yu ,Madhumita Bogdan ,Muhammad Zaeem Noman ,Santiago Parpal ,Elisabetta Bartolini ,Kris Van Moer ,Simone Caroline Kleinendorst ,Kristine Bilgrav Saether ,Lionel Trésaugues ,Camilla Silvander ,Johan Lindström ,Jodi Simeon ,Mary Jane Timson ,Hikmat Al-Hashimi ,Bryan D Smith ,Daniel L Flynn ,Andrey Alexeyenko ,Jenny Viklund ,Martin Andersson ,Jessica Martinsson ,Katja Pokrovskaja Tamm ,Angelo De Milito ,Bassam Janji

Estimating detection for salt-marsh songbirds during winter using the double-pass rope-drag technique

利用双程绳索拖曳法估算冬季盐沼鸣禽的探测率

Watts, Bryan D; Smith, Fletcher M; Hines, Chance H

Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis

Ripretinib 与 MEK 抑制剂协同作用,在 GIST 和系统性肥大细胞增多症的临床前模型中诱导细胞凋亡

Anu Gupta, Jarnail Singh, Alfonso García-Valverde, César Serrano, Daniel L Flynn, Bryan D Smith

Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages

Vimseltinib:针对腱鞘巨细胞瘤和巨噬细胞引发的疾病的精准 CSF1R 疗法

Bryan D Smith, Michael D Kaufman, Scott C Wise, Yu Mi Ahn, Timothy M Caldwell, Cynthia B Leary, Wei-Ping Lu, Gege Tan, Lakshminarayana Vogeti, Subha Vogeti, Breelyn A Wilky, Lara E Davis, Maitreyi Sharma, Rodrigo Ruiz-Soto, Daniel L Flynn

Whimbrel populations differ in trans-atlantic pathways and cyclone encounters

大西洋白腰杓鹬种群在跨大西洋迁徙路线和遭遇气旋方面存在差异。

Watts, Bryan D; Smith, Fletcher M; Hines, Chance; Duval, Laura; Hamilton, Diana J; Keyes, Tim; Paquet, Julie; Pirie-Dominix, Lisa; Rausch, Jennie; Truitt, Barry; Winn, Brad; Woodard, Paul

The annual cycle for whimbrel populations using the Western Atlantic Flyway

利用西大西洋迁徙路线的白腰杓鹬种群年度周期

Watts, Bryan D; Smith, Fletcher M; Hines, Chance; Duval, Laura; Hamilton, Diana J; Keyes, Tim; Paquet, Julie; Pirie-Dominix, Lisa; Rausch, Jennie; Truitt, Barry; Winn, Brad; Woodard, Paul

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Ripretinib (DCC-2618) 是一种针对广谱致癌和耐药 KIT 和 PDGFRA 变体的开关控制激酶抑制剂

Bryan D Smith, Michael D Kaufman, Wei-Ping Lu, Anu Gupta, Cynthia B Leary, Scott C Wise, Thomas J Rutkoski, Yu Mi Ahn, Gada Al-Ani, Stacie L Bulfer, Timothy M Caldwell, Lawrence Chun, Carol L Ensinger, Molly M Hood, Arin McKinley, William C Patt, Rodrigo Ruiz-Soto, Ying Su, Hanumaiah Telikepalli, Aj

The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors

选择性 Tie2 抑制剂 Rebastinib 阻断乳腺癌和胰腺神经内分泌肿瘤中 Tie2Hi 巨噬细胞的募集和功能

Allison S Harney, George S Karagiannis, Jeanine Pignatelli, Bryan D Smith, Ece Kadioglu, Scott C Wise, Molly M Hood, Michael D Kaufman, Cynthia B Leary, Wei-Ping Lu, Gada Al-Ani, Xiaoming Chen, David Entenberg, Maja H Oktay, Yarong Wang, Lawrence Chun, Michele De Palma, Joan G Jones, Daniel L Flynn,

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models

新型MET/TIE2/VEGFR2抑制剂altiratinib可抑制贝伐珠单抗耐药胶质母细胞瘤小鼠模型中的肿瘤生长和侵袭性

Yuji Piao ,Soon Young Park ,Verlene Henry ,Bryan D Smith ,Ningyi Tiao ,Daniel L Flynn ,John F de Groot